{
  "case_id": "MN21-36265",
  "year": 2021,
  "patient_info": {
    "age_range": "41 to 50",
    "gender": "Female"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Pharmacy",
  "treatment_subcategory": "Arthritis Rx",
  "treatments_requested": [
    {
      "name": "Abatacept",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_but_failed": [
    {
      "name": "Methotrexate",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [
    {
      "name": "Tofacitinib",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    },
    {
      "name": "Upadacitinib",
      "drug_type": "biologic",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity",
    "plan_coverage"
  ],
  "other_issues": null,
  "guidelines_support": true,
  "guidelines_not_support": false,
  "guidelines_details": "The American College of Rheumatology guideline does not recommend a target synthetic DMARD over a biologic DMARD when adjusting treatment for rheumatoid arthritis.",
  "soc_support": true,
  "soc_not_support": false,
  "soc_details": "Current medical literature supports the use of Orencia for rheumatoid arthritis with SLE overlap syndrome.",
  "study_support": true,
  "study_details": [
    {
      "study_name": "Efficacy of Orencia for Rhupus",
      "study_authors": "Ikeda and colleagues",
      "key_findings": "Orencia significantly decreased disease activity and abnormal antibody production in patients with rhupus."
    }
  ],
  "key_questions": [
    "medical_necessity"
  ],
  "expedited": true,
  "rationale": "Orencia is medically necessary for the treatment of the patient's condition, supported by guidelines and studies.",
  "reviewer_credentials": "Board certified in rheumatology, actively practicing, expert in the treatment of the enrollee\u2019s medical condition."
}